Actinium Pharmaceuticals (ATNM) Q3 2025 Earnings

8AugConfirmed
Q3 2024
Q4 2024
Q2 2025
Q3 2025
-0.51
-0.41
-0.32
-0.22

Details

Expected EPS
-0.3525
Actual EPS
-0.22
Surprise EPS
0.13
Surprise Percent
+37.59%

Description

Actinium Pharmaceuticals (ATNM) has reported earnings of -0.22 per share for Q3 2025.

0 Comments

Share your thoughts